8/ OPTIMAL LEVELS - DOSING: Don’t megadose. The sweet spot for 25(OH)D is: •30–50 ng/mL (75–125 nmol/L) •Routine doses: 800–2000 IU/day is generally safe Toxicity starts >10,000 IU/day long-term. Ref: Holick et al, J Clin Endocrinol Metab 2011 – https://t.co/b9xFmkvnIR
Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Feb 2020 – Jul 2025Where it's discussed
-
X / Twitter25 posts
-
YouTube3 videos
AI synopsis
What people are saying
The collective discussions demonstrate a high level of interest and moderate engagement, with posts referencing specific dosage ranges like 800–2000 IU/day and emphasizing the importance of avoiding megadosing, which shows thoughtful consideration of scientific details. The tone is generally informative and supportive, suggesting that the guideline updates are seen as a meaningful advancement in public health and clinical practice.
Most discussions support the updated guidelines, emphasizing safer, more tailored dosing strategies.
The topic of vitamin D supplementation and guideline changes appears highly relevant and engaging for the audience.
Comments reference detailed dosage recommendations and debates around optimal intake, showing moderate depth.
Several posts highlight how the new guidelines could influence clinical practice and personal health decisions, indicating a moderate to high impact.
Abstract in brief
- The guideline was developed by a Task Force of experts to help clinicians evaluate, treat, and prevent vitamin D deficiency, especially in those at risk, with recommendations based on systematic evidence review.
- Due to the high prevalence of deficiency across all ages and limited food sources, the Task Force recommends vitamin D supplementation tailored to age and clinical circumstances, along with measuring serum 25-hydroxyvitamin D levels for diagnosis.
- Currently, vitamin D testing is advised primarily for at-risk patients, and treatment with vitamin D2 or D3 is recommended for those diagnosed with deficiency; screening of low-risk individuals or using vitamin D for non-calcemic cardiovascular benefits is not supported by sufficient evidence.]
Top posts
Most liked on X and BlueskyShould You Still Be Taking Vitamin D? The Guidelines Just Changed. Vitamin D became a go-to supplement after the Endocrine Society’s 2011 guidelines pushed for doses up to 2,000 IU daily to keep levels above 30 ng/mL doi:10.1210/jc.2011-0385. But now, their 2024 update takes a https://t.co/i5xDcYP4uT
https://t.co/BfzWU0n5Jf https://t.co/UrmPVibQrX https://t.co/F6zzD40anm https://t.co/obSiI4s6JT
ビタミンDの1日推奨摂取量(RDI)については、年齢や妊娠の有無などによって異なる多くのガイドラインが存在する(後ほど紹介)。 2011年に内分泌学会が発表したガイドラインは、主に観察研究に基づき、低ビタミンD状態の人のケアに重点を置いていた (https://t.co/COyKiTWYmJ)。
https://t.co/7SHpJjeEMR guidelines, which recommended supplementation among all age groups.
All mentions
Examining the Effectiveness of Vitamin D Supplementation
Most people are taking way too much Vitamin D. For years, low vitamin D has been linked to various chronic diseases based on observational studies. However, randomized controlled trials, including the VITAL trial, show…
Impact of Vitamin D Deficiency on Hair Loss and Supplementation Insights
This video examines the role of vitamin D deficiency in hair loss, exploring recent studies on serum vitamin D levels in men and women, and the potential benefits of supplementation based on clinical guidelines for…
Updated Guidelines on Vitamin D Supplementation for Different Risk Groups
The guidelines have shifted toward a more targeted approach. Supplement doses vary by group, with recommendations for children, pregnant women, high-risk prediabetes individuals, and adults over 75. For others, standard…
Vitamin D
Should You Still Be Taking Vitamin D? The Guidelines Just Changed. Vitamin D became a go-to supplement after the Endocrine Society’s 2011 guidelines pushed for doses up to 2,000 IU daily to keep levels above 30 ng/mL doi:10.1210/jc.2011-0385. But now, their 2024 update takes a https://t.co/i5xDcYP4uT
RT @IntegralAnswers: 8/ OPTIMAL LEVELS - DOSING: Don’t megadose. The sweet spot for 25(OH)D is: •30–50 ng/mL (75–125 nmol/L) •Routine doses…
RT @IntegralAnswers: 8/ OPTIMAL LEVELS - DOSING: Don’t megadose. The sweet spot for 25(OH)D is: •30–50 ng/mL (75–125 nmol/L) •Routine doses…
RT @IntegralAnswers: 8/ OPTIMAL LEVELS - DOSING: Don’t megadose. The sweet spot for 25(OH)D is: •30–50 ng/mL (75–125 nmol/L) •Routine doses…
RT @IntegralAnswers: 8/ OPTIMAL LEVELS - DOSING: Don’t megadose. The sweet spot for 25(OH)D is: •30–50 ng/mL (75–125 nmol/L) •Routine doses…
8/ OPTIMAL LEVELS - DOSING: Don’t megadose. The sweet spot for 25(OH)D is: •30–50 ng/mL (75–125 nmol/L) •Routine doses: 800–2000 IU/day is generally safe Toxicity starts >10,000 IU/day long-term. Ref: Holick et al, J Clin Endocrinol Metab 2011 – https://t.co/b9xFmkvnIR
ビタミンDの1日推奨摂取量(RDI)については、年齢や妊娠の有無などによって異なる多くのガイドラインが存在する(後ほど紹介)。 2011年に内分泌学会が発表したガイドラインは、主に観察研究に基づき、低ビタミンD状態の人のケアに重点を置いていた (https://t.co/COyKiTWYmJ)。
https://t.co/7SHpJjeEMR guidelines, which recommended supplementation among all age groups.
@blindclassic_ In der Publikation zb. (https://t.co/WLIhRay9EO). Die 600-800 sind wahrscheinlich nur das Minimum um einen Mangel auszugleichen. Die D3-Tabletten die man zb. beim Arzt bekommt, haben meist auch nur 1k IE drin, was für jmd ohne Mangel fast nichts ist.
「ビタミンD欠乏症はすべての年齢層で非常に一般的であり、ビタミンDを含む食品はほとんどないことを考慮し、タスクフォースは、年齢および臨床状況に応じて、推奨される毎日の摂取量および許容上限レベルでの補給を推奨」 Journal of Clinical Endocrinology and Metabolism https://t.co/2NMV2LArIn
Referencia: 1. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2011;96:1911–30.
Referencia: 1. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2011;96:1911–30.
Referencia: 1. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2011;96:1911–30.
Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline | The Journal of Clinical Endocrinology & Metabolism | Oxford Academic https://t.co/cIO1sr0VpA
Referencias: 1. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2011;96:1911–30.
Referencia: Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2011;96:1911–30
Referencias: Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2011;96:1911–30.
3. Holick MF, et al. Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2011 Jul;96(7):1911-30.
3. Holick MF, et al. Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2011 Jul;96(7):1911-30.
3. Holick MF, et al. Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2011 Jul;96(7):1911-30.
https://t.co/BfzWU0n5Jf https://t.co/UrmPVibQrX https://t.co/F6zzD40anm https://t.co/obSiI4s6JT
RT @saludatm:
@SleymanKanbola4 @dmet_47 @esraciftci75 @DrGunerSonmez ✔Evaluation Treatment and Prevention of Vitamin D Deficiency an Endocrine Society Clinical Practice Guideline https://t.co/3wNOENsbzU
Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. - PubMed - NCBI https://t.co/p38g7MFplu
I
DS
A
AA
こ内
IP
RL
NA
DC
ET
FB
麻G
YD
DA
I
L
DH